Yesterday, Affymetrix, Inc. announced that it has signed a distribution agreement with Fisher Scientific, Inc., to distribute the GeneAtlas™ System and its related consumables in the United States and Canada. Affymetrix’s superior microarray technology will gain significant exposure through the strategic partnership as the distribution will occur primarily through Fisher Scientific’s channels. Fisher Scientific, which is affiliated with Thermo Fisher Scientific, has a leading position in the life sciences market and provides an unparalleled reach and a proven record of customer service and support.
The GeneAtlas System is the first personal microarray solution to meet the demand among life scientists for an easy to use and affordable way to interrogate the whole genome. The easy-to-use bench top design provides a complete end-to-end solution for processing the industry’s most widely cited gene expression arrays and analyzing biological pathways. With integrated data analysis designed for biologists, not bioinformaticians, and wizard-driven statistical and pathway analysis, life scientists are only nine clicks away from data to pathways when using the GeneAtlas System, the simplest microarray workflow on the market.
“We are excited to reach this agreement with Fisher Scientific because it allows us to expand our commercial sales in research markets while maintaining our focus further downstream in validation and clinical markets,” said Andy Last, Chief Commercial Officer at Affymetrix. “Now we have a partner with the industry’s strongest customer channel to take this technology to the broadest life scientist community, which is key to the GeneAtlas System’s success.”
Dan Pantano, President of Fisher Scientific, added, “We are also excited to be entering into this relationship with Affymetrix; it broadens our extensive genomic research portfolio and allows us to offer a full suite of solutions from discovery research through to validation. By partnering with the industry innovator and pioneer in microarray technology it provides Fisher Scientific an opportunity to offer customers a premium option when faced with challenging genomic research, and the GeneAtlas System is the perfect solution for many customers we routinely serve,” Pantano added.
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment